These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors. Liu S, Veilleux A, Zhang L, Young A, Kwok E, Laliberté F, Chung C, Tota MR, Dubé D, Friesen RW, Huang Z. J Pharmacol Exp Ther; 2005 Aug; 314(2):846-54. PubMed ID: 15901792 [Abstract] [Full Text] [Related]
25. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. Rutten K, Prickaerts J, Hendrix M, van der Staay FJ, Sik A, Blokland A. Eur J Pharmacol; 2007 Mar 08; 558(1-3):107-12. PubMed ID: 17207788 [Abstract] [Full Text] [Related]
26. The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo. Yamamoto S, Sugahara S, Naito R, Ichikawa A, Ikeda K, Yamada T, Shimizu Y. Eur J Pharmacol; 2006 Jul 10; 541(1-2):106-14. PubMed ID: 16780833 [Abstract] [Full Text] [Related]
28. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma. Deng YM, Xie QM, Tang HF, Sun JG, Deng JF, Chen JQ, Yang SY. Eur J Pharmacol; 2006 Oct 10; 547(1-3):125-35. PubMed ID: 16956605 [Abstract] [Full Text] [Related]
30. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. Morini M, Roccatagliata L, Dell'Eva R, Pedemonte E, Furlan R, Minghelli S, Giunti D, Pfeffer U, Marchese M, Noonan D, Mancardi G, Albini A, Uccelli A. J Neuroimmunol; 2004 Mar 10; 148(1-2):146-53. PubMed ID: 14975595 [Abstract] [Full Text] [Related]
33. The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice. Loher F, Schmall K, Freytag P, Landauer N, Hallwachs R, Bauer C, Siegmund B, Rieder F, Lehr HA, Dauer M, Kapp JF, Endres S, Eigler A. J Pharmacol Exp Ther; 2003 May 10; 305(2):549-56. PubMed ID: 12606674 [Abstract] [Full Text] [Related]
34. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats. Milicevic I, Pekovic S, Subasic S, Mostarica-Stojkovic M, Stosic-Grujicic S, Medic-Mijacevic L, Pejanovic V, Rakic L, Stojiljkovic M. J Neurosci Res; 2003 Apr 15; 72(2):268-78. PubMed ID: 12672002 [Abstract] [Full Text] [Related]
35. Rolipram, a specific type-4 phosphodiesterase inhibitor, inhibits cyclophosphamide-induced haemorrhagic cystitis in rats. Sakura M, Masuda H, Matsuoka Y, Yokoyama M, Kawakami S, Kihara K. BJU Int; 2009 Jan 15; 103(2):264-9. PubMed ID: 18710439 [Abstract] [Full Text] [Related]